We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Low-Cost Portable Sensor Detects Heavy Metals in Sweat

By LabMedica International staff writers
Posted on 24 Jan 2023

Heavy metals like lead and cadmium can be found in batteries, cosmetics, food and many other things that have become a part of daily life. More...

However, they become toxic if they accumulate in the human body and can cause several health problems. Expensive equipment and a controlled laboratory environment are usually required to detect heavy metals in body fluids. Researchers have now developed a portable sensor made of simple materials that can detect heavy metals in sweat, which is easily sampled.

Humans discharge heavy metals mostly through sweat and urine. The analysis of these biofluids forms a key part of toxicological tests as well as treatment. As compared to other gold-standard tests for detecting heavy metals in biofluids, the new sensor developed by researchers at the University of São Paulo (São Paulo, Brazil) is simple in terms of the materials used to manufacture it and the production stages it goes through. The device is connected to a potentiostat, a portable instrument that determines the concentration of each metal by measuring differences in potential and current between electrodes. The result is displayed on a computer or smartphone using appropriate application software. The system is so simple that it can be used by non-specialists without training, as well as by technicians in hospitals, clinics and doctor’s offices.

“We get important information on a person’s health by measuring their exposure to heavy metals. High levels of cadmium can lead to fatal problems in the airways, liver and kidneys. Lead poisoning damages the central nervous system and causes irritability, cognitive impairment, fatigue, infertility, high blood pressure in adults and delayed growth and development in children,” said Paulo Augusto Raymundo Pereira, last author of the article. “The world needs flexible sensors that are easily, cheaply and rapidly mass-produced, as our device is, for on-site detection, continuous monitoring and decentralized analysis of hazardous compounds.”

“The base of the device is polyethylene terephthalate (PET), on top of which is a conductive flexible copper adhesive tape, a label of the kind you can buy from a stationer’s, with the sensor printed on it, and a protective layer of nail varnish or spray,” said Robson R. da Silva, co-author of the article. “The exposed copper is removed by immersion in ferric chloride solution for 20 minutes, followed by washing in distilled water to promote the necessary corrosion. All this ensures speed, scalability, low power and low cost.”

Related Links:
University of São Paulo 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Alzheimer's Disease Biomarker Assay
Elecsys Phospho-Tau (217P) Plasma
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers combined a blood-based biomarker of Alzheimer’s disease with age, sex, and genetic risk to estimate future cognitive impairment risk in asymptomatic adults (Image Credit: Adobe Stock)

Blood Biomarker Model May Help Estimate Five- and 10-Year Cognitive Impairment Risk

Estimating future cognitive impairment risk remains challenging in cognitively healthy adults, particularly when biomarker findings are reduced to simple positive or negative results. Because mild cognitive... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Lung Cancer Atlas Reveals Cellular Patterns Associated With Patient Prognosis

Lung cancer is a leading cause of cancer-related death worldwide and is characterized by substantial cellular heterogeneity. Even within a single tumor, cancer cells can vary in aggressiveness, while immune,... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: Malaria is caused by Plasmodium parasites, primarily transmitted through the bites of infected female Anopheles mosquitoes (Image Credit: Adobe Stock)

Complete Malaria Genomes Could Improve Species Identification and Surveillance

Malaria remains a major global health challenge, with an estimated 282 million cases and 610,000 deaths worldwide in 2024. Although most research has focused on Plasmodium falciparum, Plasmodium ovale... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.